ARTICLE | Company News
CleveXel Pharma, PEP-Therapy deal
July 27, 2015 7:00 AM UTC
The companies partnered to co-develop a peptide from PEP-Therapy to treat cancer through clinical proof of concept. The cell-penetrating peptide targets the interaction between caspase-9 ( CASP9; MC...